Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 179: Obesity Effects on the Workforce & Economy with Tim Dall, Healthcare Economist
Employment Law Now: Volume 3 Episode 45- Part 1 of 2 Back From The Summer Hiatus
Polsinelli Podcast - What Employers Need to Know About Obesity in the Workplace
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®). Although...more
This order establishes a policy of the federal government to aggressively combat health challenges facing Americans, including mental health, obesity, diabetes, and other chronic diseases. The order establishes the...more
Diabetes and obesity drugs have skyrocketed in popularity as of late. According to a report released by Trilliant Health in September 2023, healthcare providers in the United States wrote more than 9 million prescriptions for...more
In recent years, increased transparency into the nutritional value of our food has enabled consumers to make more informed decisions on their own eating habits, knowing that their choices directly correlate with their overall...more
On May 15, 2013, the Equal Employment Opportunity Commission ("EEOC") updated its prior guidance regarding cancer, diabetes, epilepsy, and intellectual disabilities, so as to clarify employers' obligations under the Americans...more